Flumadine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Caraco Pharma, Inc.. The primary component is Rimantadine Hydrochloride.
Product ID | 49708-521_3f2752c1-89c7-483d-a974-e47b75ffa259 |
NDC | 49708-521 |
Product Type | Human Prescription Drug |
Proprietary Name | Flumadine |
Generic Name | Flumadine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2009-09-22 |
Marketing Category | NDA / NDA |
Application Number | NDA019649 |
Labeler Name | Caraco Pharma, Inc. |
Substance Name | RIMANTADINE HYDROCHLORIDE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2009-09-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019649 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-09-22 |
Marketing End Date | 2017-08-31 |
Ingredient | Strength |
---|---|
RIMANTADINE HYDROCHLORIDE | 100 mg/1 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FLUMADINE 73586285 1415548 Live/Registered |
HOFFMANN-LA ROCHE INC. 1986-03-05 |